Navigation Links
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results
Date:8/11/2011

cash, cash equivalents and short term investments of $47.2 million compared with $26.1 million on December 31, 2010. Pro forma cash on December 31, 2010 was approximately $64 million. The pro forma cash calculation included proceeds from the company's IPO net of underwriters' discounts and commissions.  
  • Cash used in operating activities and for the purchase of fixed assets used in investing activities ("cash burn") was approximately $17 million for the six months ended June 30, 2011.  

  • Full Year 2011 Financial Guidance

  • Pacira is reiterating its revenue expectations for 2011 and currently expects to achieve revenue in the range of $14 to $16 million for the full-year ending December 31, 2011.  This revenue expectation excludes the impact of potential sales of EXPAREL should it receive approval from the FDA in the fourth quarter of 2011.  
  • The company is reiterating that it expects cash burn, excluding the impact of any future partnerships, asset monetizations or other cash generating activities unrelated to its current operations, to be approximately $30 million cumulatively through the third quarter of 2011.  Based upon the company's new PDUFA goal date of October 28, 2011, Pacira is updating its expectation for cash burn for the fourth quarter of 2011 to approximately $15 million from its previous expectation of $25 million. This fourth quarter 2011 cash burn expectation is based upon the assumption that Pacira will commence the launch of EXPAREL in the first quarter of 2012, and therefore does not include a $10 million milestone to Skye Pharmaceuticals which will be due upon the first commercial sale of EXPAREL.  

  • Recent Developments

  • Presented new Phase 3 EXPAREL data on subjects undergoing mammoplasty: In May 2011 data from Pacira's new Phase 3 study on the use of EXPAREL in the treatment of postsurgical pain after breast augmentation surgery was presented
    '/>"/>

  • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
    2. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
    3. Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index
    4. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
    5. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
    6. Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference
    7. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
    8. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
    9. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
    10. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
    11. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
    (Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... and size the world market for Arthroscopy ... identifies trends impacting the market for these ...
    (Date:5/21/2015)... , May 21, 2015  (MUSE Booth # ... Health Record (EHR) is invaluable in any hospital ... are now a requirement and mainstream in healthcare, ... into the EHR is gaining traction in MEDITECH ... Holmes, RN, Site Project Manager & Clinical Analyst ...
    Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3
    ... Trial Supported by the Foundation Fighting Blindness ... New England Journal of Medicine, OWINGS MILLS, Md., April ... to patients who were nearly blind from,a condition known as ... Initial results from the clinical trial, which was,funded in part ...
    ... April 26 Schering-Plough Corporation,(NYSE: SGP ) ... analysis of,an ongoing Phase II study of boceprevir, ... treatment-naive patients with chronic,hepatitis C virus (HCV) genotype ... the European Association for the Study of the ...
    Cached Medicine Technology:Gene Therapy Provides Vision to People who Were Nearly Blind 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 9
    (Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
    (Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health Limited ... brand Nature’s Way, Marc St-Onge has affirmed his commitment ... is an integral part of the agreement with Nature’s ... further develop Ascenta Skin into a leading player in ... breakthrough, anti-aging skincare supplement featuring 6 active ingredients including ...
    (Date:5/22/2015)... May 22, 2015 “It’s like ... SLP, RAC-CT, CHHRP-QT, Vice President of Clinical Operations/Education ... important ‘language’ that impacts how care is coded ... in long term care reimbursement, operations and compliance ... and talent management, launches a new series of ...
    (Date:5/22/2015)... Memorial Day weekend is typically considered the beginning of ... tips to help promote safe travel. , According to estimates ... fatalities this Memorial Day weekend. Amica is sharing the following ... , , Always wear a seatbelt: ... whether they’re driving or riding along as a passenger. Seatbelts ...
    (Date:5/22/2015)... Virginia (PRWEB) May 22, 2015 ... of Health IT solutions, announced today that Bill ... Healthcare is the developer of BlueEHS,a first of ... BlueEHS offers a customizable Electronic Health Records (EHR) ... lab interfaces, a telemedicine-enabled comprehensive patient portal, and ...
    Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2
    ... ... Headache Society® and the Migraine Research Foundation are pleased to announce that Anna ... for her proposal, “Corticothalamic feedback and trigeminothalamic sensory processing during cortical spreading depression-relevance ... ...
    ... ... Recent Documentary, Comes To Race—and To Educate Others,About the Link Between Oral Health and Heart ... Vista, CA (PRWEB) ... will stand out more than most—but she’ll do it seated in her wheelchair. That person ...
    ... ... a group of individuals who started a company that specialize in the R&D and ... have decided to kickstart the commercial launch of its High Definition reading glasses named ... (PRWEB) ...
    ... , In patients with leukemia, the formation of white ... leukemia patients particularly susceptible to infections, because properly functioning white ... bacteria. In the US alone, every year around 50.000 adults ... interplay of various factors , Leukemia occurs in various ...
    ... institutions housing innumerable units, sections and visitor destinations. ... within most locales, making it difficult to comply with ... addition, about half of all Americans approximately 90 ... hospital,s written signs. These challenges have led to ...
    ... 2010 Although caffeine is the most widely ... for maintenance of proper brain functioning has only ... from epidemiological studies and fundamental research in animal ... the cognitive decline seen in dementia and Alzheimer,s ...
    Cached Medicine News:Health News:Thomas E. Heftler Migraine Research Award 2Health News:First Paraplegic Woman to Climb Mt. Kilimanjaro to Race at Vista's Strawberry Festival 2Health News:Introducing a New Generation of Reading and Computer Glasses 2Health News:Introducing a New Generation of Reading and Computer Glasses 3Health News:Gene loss causes leukemia 2Health News:UC design innovation: Healing for hospital signs that don't work 2Health News:UC design innovation: Healing for hospital signs that don't work 3Health News:UC design innovation: Healing for hospital signs that don't work 4Health News:New evidence caffeine may slow Alzheimer's disease and other dementias, restore cognitive function 2
    ... developed a minimally invasive cryocatheter to ... delivers a very high level of ... site precision, minimal tissue disruption, and ... ,Freezor Xtra allows physicians to surgically ...
    The Medtronic StableMapr catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing associated...
    ... The NAVI-STAR catheter is specifically designed for ... Our precision EP deflectable NAVI-STAR catheter houses ... tip to indicate, in real time, exact ... simultaneously collecting local electrogram information. The NAVI-STAR ...
    ... Biosense Webster offers a complete ... mapping in the atrium. The ISMUS ... for simple placement in the atrial ... on the catheter's distal tip permit ...
    Medicine Products: